Cavanaugh Sarah (CIK 0001709113)

Latest company ownership

CLDX - Celldex Therapeutics, Inc.
Role: SVP OF CORP AFFAIRS & ADMIN.
Shares held
10,103
Last filed at
Jun 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 30, 2024 Jun 3, 2024 Celldex Therapeutics, Inc. SVP OF CORP AFFAIRS & ADMIN. Sell 20.0 -20,853 -91.81% ✗ $703.3K
Aug 17, 2022 Aug 19, 2022 Celldex Therapeutics, Inc. SVP OF CORP AFFAIRS & ADMIN. Sell 17.5 -32,667 -92.71% ✗ $1.2M
Dec 8, 2021 Dec 10, 2021 Celldex Therapeutics, Inc. SVP of Corp Affairs & Admin. Sell 7.5 -7,323 -94.72% ✓ $292.9K
Nov 1, 2021 Nov 3, 2021 Celldex Therapeutics, Inc. SVP of Corp Affairs & Admin. Sell 7.5 -7,323 -94.72% ✓ $316.8K
Jun 10, 2020 Jun 11, 2020 Celldex Therapeutics, Inc. SVP of Corp Affairs & Admin. Buy 90.0 +1,050 331.23% ✗ $5.1K